Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BSP:HUSC11's 5-Year Yield-on-Cost % is not ranked *
in the REITs industry.
Industry Median: 7.38 * Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba 5-Year Yield-on-Cost % Related Terms
BSP:HUSC11 vs WELL, VTR, OHI: 5-Year Yield-on-Cost % Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba 5-Year Yield-on-Cost % vs REITs Industry
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba (BSP:HUSC11) has a 5-Year Yield-on-Cost % of 0.00 as of Aug. 17, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba and its competitors. Over the past decade, Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba's 5-Year Yield-on-Cost % has ranged from 6.85 to 11.69.
Is Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba's 5-Year Yield-on-Cost % too high?
Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba's current 5-Year Yield-on-Cost % is 0.00. Over the past 10 years, this metric has ranged from a low of 6.85 to a high of 11.69. Overall, Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba's 5-Year Yield-on-Cost % compare to WELL and VTR?
Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba's 5-Year Yield-on-Cost % of 0.00 can be compared against companies in the REITs industry. The industry median 5-Year Yield-on-Cost % is 7.38. Historically, Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba's own 5-Year Yield-on-Cost % has ranged from 6.85 to 11.69 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a REITs company?
The median 5-Year Yield-on-Cost % among REITs companies is 7.38, based on 861 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba and its competitors. For the REITs industry, the median 5-Year Yield-on-Cost % is 7.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba stock overvalued right now?
Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba (BSP:HUSC11) has a current 5-Year Yield-on-Cost % of 0.00. The stock's GF Value™ is R$33.29, compared to a current price of R$96.01 — trading 188.4% above its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba's overall GF Score™ is 44/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba (BSP:HUSC11), the current 5-Year Yield-on-Cost % is 0.00 as of Aug. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba (BSP:HUSC11) Overvalued in 2026?
Based on GuruFocus' analysis, Fundo Investimento Imobiliario Hospital Unimed SUL Capixaba stock appears to be overvalued.
The current stock price of R$96.01 is trading 188.4% above its estimated GF Value™ of R$33.29.
Key valuation signals for BSP:HUSC11:
5-Year Yield-on-Cost %: 0.00
GF Value™: R$33.29 vs. price of R$96.01 (188.4% above fair value)
No single metric tells the full story. See the BSP:HUSC11 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:HUSC11 has been successfully added to your 
